Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Rad

Showing results (161-170 of 210) with videos related to

Pageof 21
Sort By:
Nature Immunology|June 8, 2021
Skin and gut imprinted helper T cell subsets exhibit distinct functional phenotypes in central nervous system autoimmunityMichael Hiltensperger, Eduardo Beltrán, Ravi Kant, et al.
Nature Medicine|October 20, 2014
A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancerNina Schönhuber, Barbara Seidler, Kathleen Schuck, et al.
Blood|January 22, 2025
Two-layered immune escape in AML is overcome by Fcγ receptor activation and inhibition of PGE2 signaling in NK cellsCharlotte Rothfuß, Tobias Baumann, Sainitin Donakonda, et al.
Gastroenterology|August 10, 2018
Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal AdenocarcinomaUjjwal Mukund Mahajan, Eno Langhoff, Elisabetta Goni, et al.
Nature|April 12, 2021
Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoVAlexey Stukalov, Virginie Girault, Vincent Grass, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 17, 2024
A Novel AMPK Inhibitor Sensitizes Pancreatic Cancer Cells to Ferroptosis InductionCarolin Schneider, Jorina Hilbert, Franziska Genevaux, et al.
Leukemia|January 16, 2026
Strong constitutive NF-κB signaling in B cells drives SLL/CLL-like lymphomagenesis and overcomes microenvironmental dependenciesValeria Soberón, Lena Osswald, Andrew Moore, et al.
JCI Insight|May 27, 2025
Label-free single-cell phenotyping to determine tumor cell heterogeneity in pancreatic cancer in real timeKatja Wittenzellner, Manuel Lengl, Stefan Röhrl, et al.
Nature Methods|June 16, 2022
Mass spectrometry-based draft of the mouse proteomePiero Giansanti, Patroklos Samaras, Yangyang Bian, et al.
Gut|September 3, 2020
Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancerJohann Gout, Lukas Perkhofer, Mareen Morawe, et al.
Pageof 21

Showing results (161-170 of 210) with videos related to

Sort By:
Pageof 21
Nature Immunology|June 8, 2021
Skin and gut imprinted helper T cell subsets exhibit distinct functional phenotypes in central nervous system autoimmunityMichael Hiltensperger, Eduardo Beltrán, Ravi Kant, et al.
Nature Medicine|October 20, 2014
A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancerNina Schönhuber, Barbara Seidler, Kathleen Schuck, et al.
Blood|January 22, 2025
Two-layered immune escape in AML is overcome by Fcγ receptor activation and inhibition of PGE2 signaling in NK cellsCharlotte Rothfuß, Tobias Baumann, Sainitin Donakonda, et al.
Gastroenterology|August 10, 2018
Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal AdenocarcinomaUjjwal Mukund Mahajan, Eno Langhoff, Elisabetta Goni, et al.
Nature|April 12, 2021
Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoVAlexey Stukalov, Virginie Girault, Vincent Grass, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 17, 2024
A Novel AMPK Inhibitor Sensitizes Pancreatic Cancer Cells to Ferroptosis InductionCarolin Schneider, Jorina Hilbert, Franziska Genevaux, et al.
Leukemia|January 16, 2026
Strong constitutive NF-κB signaling in B cells drives SLL/CLL-like lymphomagenesis and overcomes microenvironmental dependenciesValeria Soberón, Lena Osswald, Andrew Moore, et al.
JCI Insight|May 27, 2025
Label-free single-cell phenotyping to determine tumor cell heterogeneity in pancreatic cancer in real timeKatja Wittenzellner, Manuel Lengl, Stefan Röhrl, et al.
Nature Methods|June 16, 2022
Mass spectrometry-based draft of the mouse proteomePiero Giansanti, Patroklos Samaras, Yangyang Bian, et al.
Gut|September 3, 2020
Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancerJohann Gout, Lukas Perkhofer, Mareen Morawe, et al.
Pageof 21